The statistics of phase 0 trials
- 作者Larry V. Rubinstein; Seth M. Steinberg; Shivaani Kummar; Robert Kinders; Ralph E. Parchment; Anthony J. Murgo; Joseph E. Tomaszewski; James H. Doroshow
- 卷第29卷
- 期第10期
- 印刷ISSN0277-6715
- 电子ISSN1097-0258
- 文件大小84.50KB
- 发表时间2010
- DOI10.1002/sim.3840
- 页码1072-1076
Running Average Analysis of Clinical Trial Ambulatory Blood Pressure DataMichael R. Crager and Martha A. Reitman · Biometrics · 1991
Analysis of Covariance in Parallel-Group Clinical Trials with Pretreatment BaselinesMichael R. Crager · Biometrics · 1987
Met-enkephalin, age and anatomy: A microiontophoretic study in the hippocampusHenry J. Haigler; Larry F. Cahill; Michael R. Crager; Eliot Charles · 1987
Prospective Calculation of Identification Power for Individual Genes in Analyses Controlling the False Discovery RateMichael R. Crager · 2012
Long-Term Safety of a Novel Antianginal Agent in Patients With Severe Chronic Stable Angina: The Ranolazine Open Label Experience (ROLE)Michael J. Koren; Michael R. Crager; Michael Sweeney · 2007
Generalizing the standardized hazard ratio to multivariate proportional hazards regression, with an application to clinical~genomic studiesCrager, Michael R. · Journal of Applied Statistics · 2012
A Randomized, Controlled Study of Intravenous Ganciclovir Therapy for Cytomegalovirus Peripheral Retinitis in Patients with AIDSStephen A. Spector, Thomas Weigeist, Richard B. Pollard, Douglas T. Dieterich, Tobias Samo, Constance A. Benson, David F. Busch, William R. Freeman, Paul Montague, Henry J. Kaplan, Lois Kellerman, Michael Crager, Bernadette De Armond, William Buhles and Judith Feinberg · The Journal of Infectious Diseases · 1993